Serology tests could play a critical role in the fight against COVID-19. Serology tests may help determine who can donate convalescent plasma—a part of the blood containing antibodies—which is currently being explored as an investigational treatment for those with COVID-19. Convalescent plasma has been studied in outbreaks of other respiratory infections as well, including the 2003 SARS and 2012 MERS epidemics. Recognizing this, FDA updated guidance regarding convalescent plasma on Friday.
Read the alert on our Class Dismissed blog.